Featured / Mar 20

Novartis in the Philippines: actions to mitigate COVID-19 impact

Novartis continues to closely monitor the COVID-19 situation in the Philippines. Our focus is to protect the health and safety of our associates, the healthcare professionals we engage with daily, and to ensure the supply of our medicines.

Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics.